Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials
about
sameAs
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityWhat is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokeWhat's new in stroke prevention and treatmentTriflusal: an antiplatelet drug with a neuroprotective effect?My health: whose responsibility? Low-dose aspirin and older peopleRemote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic AttackPreventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic strokeAntithrombotic Utilization Trends after Noncardioembolic Ischemic Stroke or TIA in the Setting of Large Antithrombotic Trials (2002-2009).Antiplatelet therapy in secondary stroke prevention--state of the artBaseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDPlatelet hyperactivity in type 2 diabetes: role of antiplatelet agents.Medical and surgical management of symptomatic carotid stenosis.Systematic reviews as a tool for planning and interpreting trials.Antithrombotic medication for stroke prevention.Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.Antiplatelet strategies for secondary prevention of stroke and TIA.Stroke in patients with occlusion of the internal carotid artery: options for treatment.Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention.Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?Atherothrombosis and the role of antiplatelet therapyTesting Devices for the Prevention and Treatment of Stroke and its ComplicationsTreatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials
P2860
Q21144269-26FB505A-A0C3-4EBF-B3CB-40F6CAC99403Q28192878-C6F76B99-289C-4F98-A056-3F75C60A6092Q28194573-47BE6E1D-2965-4419-80AB-6B137F29656BQ28194923-52807F37-D61A-49FD-A22C-382902D51ADDQ28200341-E47C41EF-22E7-4FB5-A4B0-A46ECC63BEE2Q28201631-4AEF1F14-C0F2-426D-9379-33B2E783A9FCQ33775718-B296518F-60D9-421C-9FE2-A487D39791DFQ34092629-D349657D-3843-4C18-8307-FD0E2AB17FA1Q34367350-53BCC430-56C8-4B6A-BCA1-D217DA0B31F4Q35200772-F2EAD0EB-64C3-415D-89EB-679352B511A1Q35216412-A59B5B05-230F-45F0-9B26-9A5C3D7BF16AQ36259205-EBC0D6F9-DEA7-4E8A-B16C-9B0507E2E3CFQ36412659-9E6EB7C4-7B28-4F92-B9A3-B7EF5E184F7FQ36866370-8FBDEEAC-D550-48E1-898A-2AF3954E58A1Q37184596-AF07C362-F10F-423F-A27A-B061030799EEQ37244590-B964AB47-FD8D-4170-8D7F-6E79C9BE0B0EQ37399439-C7A0978A-5629-40BD-8797-ED5B978182FFQ37611046-08CE6194-0EE5-48A1-A102-FF68786721C7Q37636343-F93AE090-AEA2-4490-909A-615FC4C4639FQ38247544-7206E839-7F62-43A0-BD4E-B34F62E3A525Q38253242-E5256345-7E30-4354-B9C1-7C2FC9DE5F71Q38896828-0EE199F1-73F4-493E-804E-66A28B6EDAECQ42676674-B132B27D-D5B8-4DA9-85AF-00F1CC6224E5Q46393304-44108958-E1AE-497E-89D8-8AEB5A5B8F30Q46427553-87D3D669-277F-4894-B077-D1FE873827B8Q57243374-EDDDDF0C-F459-4808-A3C3-014107CA09CAQ58209282-E59DCE89-C3C7-48BC-8B43-62F5AF33F51EQ58438976-0AB19EA2-171A-414A-9FF3-53A3A0F1E953
P2860
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dipyridamole for preventing re ...... m randomized controlled trials
@ast
Dipyridamole for preventing re ...... m randomized controlled trials
@en
Dipyridamole for preventing re ...... m randomized controlled trials
@nl
type
label
Dipyridamole for preventing re ...... m randomized controlled trials
@ast
Dipyridamole for preventing re ...... m randomized controlled trials
@en
Dipyridamole for preventing re ...... m randomized controlled trials
@nl
prefLabel
Dipyridamole for preventing re ...... m randomized controlled trials
@ast
Dipyridamole for preventing re ...... m randomized controlled trials
@en
Dipyridamole for preventing re ...... m randomized controlled trials
@nl
P2093
P50
P1433
P1476
Dipyridamole for preventing re ...... m randomized controlled trials
@en
P2093
Antoni Davalos
Bernard Guiraud-Chaumeil
Frank Yatsu
Juhani Sivenius
P356
10.1161/01.STR.0000149621.95215.EA
P407
P577
2005-01-01T00:00:00Z